GIGABYTE-TECHNOLOGY
4.6.2021 11:38:50 CEST | Business Wire | Press release
GIGABYTE Technology, a leading brand of computer innovations, continues its strong presence at COMPUTEX, joining the “#COMPUTEXVirtual” platform as the exhibition takes place online due to global pandemic situation. From May 31st to June 30th , GIGABYTE orchestrated 10 different sections in a dedicated “GIGABYTE Pavilion” to exhibit a series of products and solutions that can expand on its “Bring Smart to Life” concept, from the data center to personal computer, and 5G to edge AI computing.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210604005208/en/
GIGABYTE is known for having the most extensive portfolio of AMD servers for demanding workloads, and has readied a comprehensive lineup of servers supporting the 7nm processor, unlocking its incredible performance of up to 64 cores and 128 threads to enable developers and scientists to tackle challenges in HPC and cloud computing. Correspondingly, GIGABYTE is primed to present Intel servers based on the latest 3rd Gen. Intel® Xeon® Scalable Processors suited for enterprises looking to upgrade their IT infrastructure.
At the forefront of server development is an NVIDIA Arm HPC Developer Kit, a system that includes an Ampere Altra processor, two NVIDIA A100 Tensor Core GPUs, and two NVIDIA BlueField®-2 DPUs, all contained in a leading-edge GIGABYTE G242 server. In addition, GIGABYTE will present four ARM server products, all of which can leverage the power of the 80-core (250W) Ampere Altra processors to provide outstanding efficiency, performance, and throughput.
Smart cities benefited from the computing power of data centers through GIGABYTE’s industrial motherboards, embedded systems, automotive electronics, 3D depth sensing solutions, visual recognition solutions, and deep learning-based AI training and inferencing programs. Notable exhibits will include Industry 4.0 factory automation and smart retail solutions, in-vehicle ECU and AI edge computing platforms, and AI facial recognition systems.
PC consumers are treated with AORUS and AERO premium laptops, now powered by Intel’s latest 11th Gen Tiger Lake-H series processors, while pairing with the full-power RTX 30 series graphics cards and 4K OLED panels respectively; new AORUS 4K gaming monitors equipped with exclusive tactical game-enhancement features and HDMI 2.1-ready for full support of the new-gen gaming consoles; and two prebuilt AORUS flagship systems that are the world’s first factory-tuned gaming desktops, with the most powerful component to date, and tuned and tested to ensure impeccable stability and performance out of the box.
Visit “GIGABYTE Pavilion”
https://virtual.computextaipei.com.tw/area/gigabyte/
View source version on businesswire.com: https://www.businesswire.com/news/home/20210604005208/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FuzeBox AI Named Founding Co-Author of SPUR Coalition Technical Committee on Verifying AI Content Use5.10.2026 15:00:00 CEST | Press release
A new technical committee will define how publishers can independently confirm AI companies' reports of content use. FuzeBox AI has been named by the SPUR Coalition, an international nonprofit of 37 news and media organizations, as one of four founding co-authors of its Evidence Profile Technical Committee, adopted Sept. 2, 2026, to draft an evidence profile for SPUR's Content Telemetry standard: a way for publishers to verify AI usage reports without depending on the reporting company's cooperation. Under SPUR's current standard, AI companies self-report their content use. A company that skips reporting leaves no record, and publishers can't check what they do receive. On July 10, 2026, FuzeBox proposed its Verified Provenance Telemetry Standard (VPTS): publishers seed content with detectable markers, then verify their appearance in AI outputs via an auditable ledger, with no change to SPUR's standard. Within 48 hours, three organizations filed related proposals: ProRata on usage magn
Mary Kay Introduces the K-Beauty Texture Edit5.10.2026 14:02:00 CEST | Press release
Special-Edition Korea-Made Skin Care Collection Launches In 40 Markets, Available While Supplies Last Mary Kay Inc.,the iconic beauty giant announced today the launch of the K-Beauty Texture Edit, aspecial-edition skin care collection available while supplies last. The collection builds on the momentum of the company's largest consumer-facing global brand platform, Beauty Is More Beautiful Shared™ which launched in September. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005600130/en/ Mary Kay's Special Edition K-Beauty Texture Edit is a trend-forward collection which includes three Korea-made products: the Mary Kay® Melt-In Cleansing Balm, Mary Kay® Snail Gel Face Patches and Mary Kay® Collagen Moisturizing Gel. (Image Credit: Mary Kay Inc.) Inspired by Korea's globally influential skin care and self-care philosophy designed to bring playful textures, innovative ingredients, and elevated beauty experiences, the K-Beauty
GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.5.10.2026 14:00:00 CEST | Press release
Broadens GE HealthCare's footprint in the U.S. radiopharmaceutical industry, drives patient access to F18 labeled Positron Emission Tomography (PET) radiopharmaceuticals and enhances exposure to new high-growth areas Pharmaceutical Diagnostics (PDx) continues to partner with other established Contract Manufacturing Organizations (CMOs) to drive and expand patient access to its radiopharmaceutical portfolio, while SOFIE Biosciences continues to supply PET products from other leading radiopharmaceutical providers Provides U.S. rights to FAPI-74, a Phase III pipeline PET radiotracer with pan-cancer imaging potential, aiming to be among the first-to-launch in a large and fast-growing market1 GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subje
Henkell Freixenet Strengthens Premium Dealcoholized Sparkling Wine Production with Solos' Patented Aroma Recovery System5.10.2026 13:24:00 CEST | Press release
The installation marks a significant step in the evolution of premium No/Low wines, where preserving aroma and sensory quality has become a defining industry priority. Henkell Freixenet is expanding its premium dealcoholized sparkling wine production capabilities through the deployment of Solos Technology's patented Aroma Recovery System (ARS) at its Wiesbaden production site, the Group’s expertise centre for alcohol-free production. The installation represents a significant investment in next-generation dealcoholized sparkling wine production, helping preserve the natural aroma and sensory identity of the original wines. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005959301/en/ Fürst von Metternich Riesling Alcohol-free on the bottling line, one of the first products in Henkell Freixenet’s portfolio developed in collaboration with Solos Technology. The project combines Henkell Freixenet's longstanding winemaking exper
Croma-Pharma Expands Its Portfolio in Canada With saypha® lips Lidocaine and Exprecell™5.10.2026 13:12:00 CEST | Press release
Croma-Pharma continues to build its portfolio in Canada, adding saypha® lips Lidocaine, a hyaluronic acid filler for lip augmentation,1 and Exprecell™, a medical device for the preparation of autologous PRP | Fluid-PRF.2 Both are distributed by Renellence, Croma's partner in Canada since 2025. The two additions reflect Croma's broader approach: pairing established hyaluronic acid expertise with autologous, regenerative technologies. Together, they give practitioners options across both aesthetic and regenerative treatment categories, from a single trusted source. "With saypha® lips Lidocaine and Exprecell™, we're giving Canadian practitioners a wider set of tools for facial aesthetics and regenerative treatments, each held to the same standard of precision and safety," said Andreas Prinz, Chief Executive Officer of Croma-Pharma GmbH. Renellence has distributed Croma's Saypha® hyaluronic acid filler range in Canada since October 2025, alongside medical education and training for Canadia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom